Suchergebnisse - "Jacobson, Ira M"

PubPharm (341)

1

Monitoring for liver cancer post-gene therapy-How much and how often?

enthalten in: Journal of viral hepatitis | 2024

von P de Jong, Y. | Jacobson, I.

2

Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States : An analysis of the All-Payer Claims Database

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Gish, R. | Jacobson, I. | Lim, J. | +5

3

Long-term open-label vebicorvir for chronic HBV infection : Safety and off-treatment responses

enthalten in: JHEP reports : innovation in hepatology | 2024

von Yuen, M. | Fung, S. | Ma, X. | +28

4

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Kowdley, K. | Bowlus, C. | Levy, C. | +102

5

Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus Treatment

enthalten in: Gastroenterology & hepatology | 2024

von Jacobson, I.

6

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2) : A Randomized Phase 2b Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Abdelmalek, M. | Sanyal, A. | Nakajima, A. | +17

7

Monitoring for liver cancer post‐gene therapy—How much and how often?

enthalten in: Journal of Viral Hepatitis | 2024

von de Jong, Y. | Jacobson, I.

8

Chronic Hepatitis B : Treat all Who Are Viremic?

enthalten in: Clinics in liver disease | 2023

von Su, F. | Jacobson, I.

9

Correction to : Diagnosis and Management of Hepatitis Delta Virus Infection

enthalten in: Digestive diseases and sciences | 2023

von Pan, C. | Gish, R. | Jacobson, I. | +3

ErratumFor: Dig Dis Sci. 2023 Aug;68(8):3237-3248. - PMID 37338616

10

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]